BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 25684695)

  • 1. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
    Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.
    Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS
    Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma.
    Stühler V; Rausch S; Kroll K; Scharpf M; Stenzl A; Bedke J
    World J Urol; 2021 Sep; 39(9):3367-3376. PubMed ID: 33638011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of the site of invasion in T3aN0M0 clear cell renal cell carcinoma.
    Guo S; Liu Z; Li X; Yao K; Dong P; Chen D; Liao C; Long Z; Wang Y; Zhou F; He X; Liu Z
    Urol Oncol; 2019 May; 37(5):301.e11-301.e17. PubMed ID: 30704960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of individual and cumulative sites of extrarenal tumor invasion in pT3a clear cell renal cell carcinoma.
    Flood TA; Hogan K; Lavallée LT; Breau RH; Morash C; Belanger EC; Schieda N
    Urol Oncol; 2020 Feb; 38(2):42.e13-42.e18. PubMed ID: 31740333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.
    Siemer S; Lehmann J; Loch A; Becker F; Stein U; Schneider G; Ziegler M; Stöckle M
    J Urol; 2005 Jan; 173(1):33-7. PubMed ID: 15592020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluation of renal cell carcinoma and perirenal fat invasion only.
    Jeon HG; Jeong IG; Kwak C; Kim HH; Lee SE; Lee E
    J Urol; 2009 Nov; 182(5):2137-43. PubMed ID: 19758661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasion of renal sinus fat is not an independent predictor of survival in pT3a renal cell carcinoma.
    Poon SA; Gonzalez JR; Benson MC; McKiernan JM
    BJU Int; 2009 Jun; 103(12):1622-5. PubMed ID: 19154464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To stage or not to stage: determining the true clinical significance of the biopsy tract through perinephric fat in assessing renal cell carcinoma.
    Valencia-Guerrero A; Oliva E; Wu CL; Wu S; Rice-Stitt T; Sadow PM; Dahl DM; Feldman AS; Arellano RS; Cornejo KM
    Histopathology; 2021 Jun; 78(7):951-962. PubMed ID: 33236381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of tumor size in renal cell cancer with perinephric fat infiltration: is TNM staging system adequate for predicting prognosis?
    Süer E; Baltaci S; Burgu B; Aydoğdu Ö; Göğüş Ç
    Urol J; 2013; 10(1):774-9. PubMed ID: 23504681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of renal vein involvement in T3a renal cancer.
    Clark KF; Risendal M; Hill S; Deem S
    Can J Urol; 2019 Apr; 26(2):9715-9719. PubMed ID: 31012835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinephric and Sinus Fat Invasion in Stage pT3a Tumors Managed by Partial Nephrectomy.
    Mouracade P; Dagenais J; Chavali JS; Kara O; Nelson RJ; Maurice MJ; Reese J; Rini BI; Kaouk JH
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1077-e1082. PubMed ID: 28818550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
    Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
    BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of tumor diameter on prognosis in patients with renal cancer stage pT3a.].
    Bengió RG; Arribillaga L; Montedoro A; Bengió V; Epelde J; Cordero E; García Onto H; Bengió RH
    Arch Esp Urol; 2018 Jun; 71(5):480-485. PubMed ID: 29889038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.
    Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T
    Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.